Menu

NIDA Weighs In on Pot

Addiction is one among many potential adverse effects of the increasingly popular drug, according to the National Institute on Drug Abuse.

Jun 9, 2014
Bob Grant

WIKIMEDIA, ROTATIONALMarijuana use may carry a number of risks, including addiction and memory impairment, according to a review of the scientific literature authored by the National Institute on Drug Abuse (NIDA). The authors of the review, published last week (June 5) in The New England Journal of Medicine, stressed marijuana’s potential harm to younger users, citing studies conducted on adolescents considering cognitive impairment, school performance, and social factors. “It is important to alert the public that using marijuana in the teen years brings health, social, and academic risk,” lead author and NIDA Director Nora Volkow said in a statement. “Physicians in particular can play a role in conveying to families that early marijuana use can interfere with crucial social and developmental milestones and can impair cognitive development.” The authors admitted, however, the existence of “inconsistencies” among these studies, with some showing that the long-term effects of adolescent marijuana use may be subtle, and reversible once a person quits using the drug.

The authors also discussed marijuana’s oft-cited role as a gateway drug, highlighting rodent studies that seem to support pot’s role in priming the brain for enhanced responses to other drugs. But they conceded that “an alternative explanation is that people who are more susceptible to drug-taking behavior are simply more likely to start with marijuana because of its accessibility and that their subsequent social interactions with other drug users would increase the probability that they would try other drugs.”

In the end, the authors called for more research into the potential costs and benefits of marijuana use, cautioning that whatever harm the drug does is likely to become more prevalent as medicinal and recreational pot prohibition erodes. “As policy shifts toward legalization of marijuana,” they wrote, “it is reasonable and probably prudent to hypothesize that its use will increase and that, by extension, so will the number of persons for whom there will be negative health consequences.”

April 2019

Will Car T Cells Smash Tumors?

New trials take the therapy beyond the blood

Marketplace

Sponsored Product Updates

Myth Busting: The Best Way to Use Pure Water in the Lab
Myth Busting: The Best Way to Use Pure Water in the Lab
Download this white paper from ELGA LabWater to learn about the role of pure water in the laboratory and the advantages of in-house water purification!
Shimadzu's New Nexera UHPLC Series with AI and IoT Enhancements Sets Industry Standard for Intelligence, Efficiency and Design
Shimadzu's New Nexera UHPLC Series with AI and IoT Enhancements Sets Industry Standard for Intelligence, Efficiency and Design
Shimadzu Corporation announces the release of the Nexera Ultra High-Performance Liquid Chromatograph series, incorporating artificial intelligence as Analytical Intelligence, allowing systems to detect and resolve issues automatically. The Nexera series makes lab management simple by integrating IoT and device networking, enabling users to easily review instrument status, optimize resource allocation, and achieve higher throughput.
IDT lowers genomic barriers with powerful rhAmpSeq™ targeted sequencing system
IDT lowers genomic barriers with powerful rhAmpSeq™ targeted sequencing system
Increasing accuracy and reducing cost barriers, IDT’s innovative system delivers simple and cost-effective amplicon sequencing
Bio-Rad Introduces Isotype-Specific Secondary Antibodies
Bio-Rad Introduces Isotype-Specific Secondary Antibodies
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of its isotype-specific secondary antibodies. This new range of recombinant monoclonal antibodies, directed against the three main mouse isotypes: IgG1, IgG2a, and IgG2b, offer improved signal detection and specificity in imaging, ELISA, flow cytometry, and western blotting.